Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Maryam Naseroleslami, Masuomeh Sharifi, Kamran Rakhshan, Behnaz Mokhtari & Nahid Aboutaleb. (2023) Nesfatin-1 attenuates injury in a rat model of myocardial infarction by targeting autophagy, inflammation, and apoptosis. Archives of Physiology and Biochemistry 129:1, pages 122-130.
Read now
Read now
Noha I. Hussien, Ayman M. Mousa & Abeer A. Shoman. (2022) Decreased level of plasma nesfatin-1 in rats exposed to cell phone radiation is correlated with thyroid dysfunction, oxidative stress, and apoptosis. Archives of Physiology and Biochemistry 128:6, pages 1486-1492.
Read now
Read now
Sadaf Nezamoleslami, Mohammad Sheibani, Fatemeh Jahanshahi, Faiza Mumtaz, Ata Abbasi & Ahmad Reza Dehpour. (2020) Protective effect of dapsone against renal ischemia-reperfusion injury in rat. Immunopharmacology and Immunotoxicology 42:3, pages 272-279.
Read now
Read now
Yayun Xu & Feihu Chen. (2020) Antioxidant, Anti-Inflammatory and Anti-Apoptotic Activities of Nesfatin-1: A Review. Journal of Inflammation Research 13, pages 607-617.
Read now
Read now
Articles from other publishers (25)
Zhikai Jiang, Kaitao Wang, Yuting Lin, Taotao Zhou, Yi Lin, Jianpeng Chen, Qicheng Lan, Zhefeng Meng, Xuao Liu, Hang Lin & Dingsheng Lin. (2023) Nesfatin-1 regulates the HMGB1-TLR4-NF-κB signaling pathway to inhibit inflammation and its effects on the random skin flap survival in rats. International Immunopharmacology 124, pages 110849.
Crossref
Crossref
José Arimatéa de Oliveira Nery Neto, Victor Yuji Yariwake, Niels Olsen Saraiva Câmara & Vinicius Andrade-Oliveira. (2023) Enteroendocrine cells and gut hormones as potential targets in the crossroad of the gut-kidney axis communication. Frontiers in Pharmacology 14.
Crossref
Crossref
Ganesh Panditrao Lahane & Arti Dhar. (2023) Nesfatin-1 peptide protects rat renal epithelial cells against high glucose and H2O2 induced injury via inhibition of oxidative stress, apoptosis, and fibrosis. Peptides 165, pages 171013.
Crossref
Crossref
Joanna Gajewska, Jadwiga Ambroszkiewicz, Katarzyna Szamotulska, Grażyna Rowicka, Małgorzata Strucińska, Witold Klemarczyk & Magdalena Chełchowska. (2023) Associations between Oxidant/Antioxidant Status and Circulating Adipokines in Non-Obese Children with Prader–Willi Syndrome. Antioxidants 12:4, pages 927.
Crossref
Crossref
Ragaa Abdelshaheed Matta, Sahar Hossam El-Hini, Ahmed Mohamed Saad Eldin Salama & Hend Mohamed Moaness. (2022) Serum nesfatin-1 is a biomarker of pre-diabetes and interplays with cardiovascular risk factors. The Egyptian Journal of Internal Medicine 34:1.
Crossref
Crossref
Srashti Gopal Goyal & Arti Dhar. (2022) Downregulation of nesfatin-1 expression in acute kidney injury in vivo in wistar rats and in vitro in cultured cells. Life Sciences 305, pages 120762.
Crossref
Crossref
Yayun Xu, Zhuoyan Zai, Tao Zhang, Longfei Wang, Xuewen Qian, Dandan Xu, Jingjing Tao, Zheng Lu, Zhengyu Zhang, Xiaoqing Peng & Feihu Chen. (2022) Nesfatin-1 exerts protective effects on acidosis-stimulated chondrocytes and rats with adjuvant-induced arthritis by inhibiting ASIC1a expression. Laboratory Investigation 102:8, pages 859-871.
Crossref
Crossref
Qing Zhou, Ying Liu, Ranran Feng & Wenling Zhang. (2022) NUCB2: roles in physiology and pathology. Journal of Physiology and Biochemistry 78:3, pages 603-617.
Crossref
Crossref
Neslihan Tezcan, Zarife Nigâr Özdemir-Kumral, Naziye Özkan Yenal, Özlem T Çilingir-Kaya, Aysin Tulunay Virlan, Dilek Özbeyli, Şule Çetinel, Berrak Ç Yeğen & Mehmet Koç. (2022) Nesfatin-1 treatment preserves antioxidant status and attenuates renal fibrosis in rats with unilateral ureteral obstruction. Nephrology Dialysis Transplantation 37:7, pages 1238-1248.
Crossref
Crossref
Zahra Abbasi, Mehdi Khaksari, Asghar Shayannia, Moslem Jafarisani, Ghasem Abbaszadeh-Goudarzi, Simin Nazarnezhad & Majid Rahmati. (2022) Protection of the PC12 Cells by Nesfatin-1 Against Methamphetamine-Induced Neurotoxicity. International Journal of Peptide Research and Therapeutics 28:4.
Crossref
Crossref
Omer Erdogan, Mehmet Çetinkaya, Hayrettin Sahin, Hasan Deliktas, Yelda Dere, Mustafa Yılmaz, Kursad Tosun & Serdar Aktas. (2020) Investigation of the protective effect of nesfatin‐1 on testicular ischaemia‐reperfusion damage: An experimental study. Andrologia.
Crossref
Crossref
Tommaso Angelone, Carmine Rocca & Teresa Pasqua. (2020) Nesfatin-1 in cardiovascular orchestration: From bench to bedside. Pharmacological Research 156, pages 104766.
Crossref
Crossref
A. Ranjan, M. Choubey, T. Yada & A. Krishna. (2019) Nesfatin-1 ameliorates type-2 diabetes-associated reproductive dysfunction in male mice. Journal of Endocrinological Investigation 43:4, pages 515-528.
Crossref
Crossref
R. Ciccimarra, S. Bussolati, F. Grasselli, S. Grolli, M. Paolucci & G. Basini. (2020) Potential physiological involvement of nesfatin-1 in regulating swine granulosa cell functions. Reproduction, Fertility and Development 32:3, pages 274.
Crossref
Crossref
Ashutosh Ranjan, Mayank Choubey, Toshihiko Yada & Amitabh Krishna. (2019) Immunohistochemical localization and possible functions of nesfatin-1 in the testis of mice during pubertal development and sexual maturation. Journal of Molecular Histology 50:6, pages 533-549.
Crossref
Crossref
Gülser Karadaban Emir, Yasemin Ünal, Nigar Yılmaz, Kürsad Tosun & Gülnihal Kutlu. (2019) The association of low levels of nesfatin-1 and glucagon-like peptide-1 with oxidative stress in Parkinson’s disease. Neurological Sciences 40:12, pages 2529-2535.
Crossref
Crossref
Simin Nazarnezhad, Majid Rahmati, Asghar Shayannia, Zahra Abbasi, Majid Salehi & Mehdi Khaksari. (2019) Nesfatin-1 protects PC12 cells against high glucose-induced cytotoxicity via inhibiting oxidative stress, autophagy and apoptosis. NeuroToxicology 74, pages 196-202.
Crossref
Crossref
Yusaku Mori, Hiroyuki Shimizu, Hideki Kushima, Tomomi Saito, Munenori Hiromura, Michishige Terasaki, Masakazu Koshibu, Hirokazu Ohtaki & Tsutomu Hirano. (2019) Nesfatin-1 suppresses peripheral arterial remodeling without elevating blood pressure in mice. Endocrine Connections 8:5, pages 536-546.
Crossref
Crossref
Sohaila Erfani, Ali Moghimi, Nahid Aboutaleb & Mehdi Khaksari. (2018) Protective effects of Nesfatin-1 peptide on cerebral ischemia reperfusion injury via inhibition of neuronal cell death and enhancement of antioxidant defenses. Metabolic Brain Disease 34:1, pages 79-85.
Crossref
Crossref
Hai-Lun Li, Zhuan Yan, Zun-Ping Ke, Xiao-Feng Tian, Li-Li Zhong, Yong-Tao Lin, Yong Xu & Dong-Hui Zheng. (2018) IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKI. Oncotarget 9:93, pages 36551-36560.
Crossref
Crossref
Sohaila Erfani, Ali Moghimi, Nahid Aboutaleb & Mehdi Khaksari. (2018) Nesfatin-1 Improve Spatial Memory Impairment Following Transient Global Cerebral Ischemia/Reperfusion via Inhibiting Microglial and Caspase-3 Activation. Journal of Molecular Neuroscience 65:3, pages 377-384.
Crossref
Crossref
MohamedA Korani & Ahmed Sonbol. (2018) The relation between plasma levels of nesfatin-1 and different grades of diabetic kidney disease in patients with type 2 diabetes. The Egyptian Journal of Internal Medicine 30:2, pages 68.
Crossref
Crossref
Philip Prinz & Andreas Stengel. (2016) Nesfatin-1: current status as a peripheral hormone and future prospects. Current Opinion in Pharmacology 31, pages 19-24.
Crossref
Crossref
Mete Ozcan, Zeynep Betul Gok, Emine Kacar, Ihsan Serhatlioglu & Haluk Kelestimur. (2016) Nesfatin-1 increases intracellular calcium concentration by protein kinase C activation in cultured rat dorsal root ganglion neurons. Neuroscience Letters 619, pages 177-181.
Crossref
Crossref
Sandra M. Sancho-Martínez, José M. López-Novoa & Francisco J. López-Hernández. (2015) Pathophysiological role of different tubular epithelial cell death modes in acute kidney injury. Clinical Kidney Journal 8:5, pages 548-559.
Crossref
Crossref